Developer docs
API playgroundTry for free, no card

Search company profiles

Menapharm Consulting

Full company profile

uuid004vnbd

Namestring
Menapharm Consulting
Legal namestring
CPC Limited
Websiteurl
menapharm.eu
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Menapharm Consulting is a pharmaceutical market-entry and operations consulting firm that helps drug companies establish and run commercial presence across the Middle East and Africa. The company delivers four integrated services: Business Analysis (compliance checks, market research, SWOT, regulatory strategy, 5-year business plans), Regulatory Support (registration requirements, dossier compilation, submissions, variations, renewals), Distributor Management (selection, contract negotiation, inventory, sales reporting), and Marketing & Promotion (brand management, training materials, medical rep recruitment and management, forecasting and budgeting). Together these services function as a de facto regional office for clients that want MEA exposure without bearing the overhead of setting one up themselves.

The business model is professional-services based: engagements are quote-based with a shared-risk pricing structure, targeted exclusively at enterprise pharmaceutical clients. Go-to-market is relationship-driven and event-led, anchored on appearances at CPhI Worldwide (Milan, October 2026), WHX Dubai (January 2027) and Arab Health, supplemented by direct outreach via the company website. Disclosed clients include Leader Pharma (US), MAR-FARMA SRL (Italy, engaged since 2016) and TECNIMEDE GROUP (Portugal). The firm operates with nine employees from a Maltese headquarters (Lija) and a regional office in Abu Dhabi, with additional presence in the United Kingdom.

Following a recent merger with CPC Limited, Menapharm is now legally registered as CPC Limited in Malta while continuing to operate under the Menapharm brand. The company maintains a network of strategic partners and vetted distributors across MEA markets, which collectively represent a potential market access of approximately 850 million people. The MEA pharmaceuticals market is projected to grow from USD 30.1 billion in 2024 to USD 42.4 billion by 2030 at a 6.1% CAGR, providing the underlying tailwind for Menapharm's niche offering.

Short descriptiontext

Menapharm Consulting is a Malta-based pharmaceutical consulting firm that helps drug companies enter and operate in Middle East and African markets through four integrated services: business analysis, regulatory support, distributor management, and marketing and promotion.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLija, Malta
HQ citystring
Lija
HQ countrystring
Malta
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical consulting services, market entry consulting, regulatory affairs consulting, pharmaceutical distributor management, Middle East Africa consulting
Industry1 code
PRIMARYBPAHAIAM
Instrumentation, Controls & Automation Engineering Consulting
NAICS code2 codes
  • Management Consulting Services54161
  • Other Management Consulting Services541618
SIC code1 code
  • Services-Management Consulting Services8742
Product category
Pharmaceutical Market Consulting
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Consulting Services
TypeProfessional Services
Description

Menapharm generates revenue through a range of consulting and advisory services including business analysis, regulatory support, distributor management, and marketing & promotion services. These are professional services billed to pharmaceutical companies seeking market entry in the Middle East and Africa.

menapharm.eu
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Menapharm Consulting provides pharmaceutical manufacturers with market entry and operational support services in the Middle East and African (MEA) markets. The firm offers business analysis, regulatory support, distributor management, and marketing & promotion services designed to help pharmaceutical companies establish or expand their presence in the MEA region without the overhead of setting up their own local offices.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Speed to market as the key competitive advantage
Product overview1 text field

Menapharm Consulting offers a unified portfolio of four integrated consulting services for pharmaceutical companies seeking to enter Middle East and African markets. The core offering comprises Business Analysis (compliance checks, market research, and strategic planning), Regulatory Support (registration, dossier compilation, and compliance), Distributor Management (selection, negotiation, and ongoing management), and Marketing & Promotion (brand management, medical rep training, and sales support). These services function as a coordinated suite, providing the full scope of support equivalent to a regional office without the overhead costs, with a shared-risk business model designed to reduce market entry risk while enabling fast and efficient market penetration.

Product and service4 records
1Business Analysis
CategoryPharmaceutical Market Consulting
Description

Market and business analysis service for pharmaceutical companies assessing entry or expansion into the Middle East and African markets. Delivered to pharmaceutical manufacturers seeking data-driven entry strategies.

2Regulatory Support
CategoryRegulatory Affairs Consulting
Description

Regulatory affairs consulting service that helps pharmaceutical manufacturers navigate product registration, licensing, and compliance requirements across MEA jurisdictions.

3Distributor Management
CategoryPharmaceutical Distribution Services
Description

Service that identifies, vets, and manages pharmaceutical distributors across Middle East and African markets on behalf of pharmaceutical manufacturers seeking local commercial partners.

4Marketing & Promotion
CategoryPharmaceutical Marketing Services
Description

Marketing and product promotion services supporting pharmaceutical launches and ongoing brand activities across the Middle East and African markets.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Menapharm has merged with CPC Limited and will be registered as CPC Limited in Malta. They continue to operate under the Menapharm brand, which is widely recognized as a leading service provider to the pharma industry in the Middle East markets. This merger strengthens their operational infrastructure while maintaining their brand identity.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Customer testimonial partner. Dev Kumar, CCO, provided testimonial praising Menapharm's expertise in helping establish pharmaceutical presence in MENA markets.

3MAR-FARMA SRL (Italy)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Customer testimonial partner. Roberto Ricatti, CEO, has been working with Menapharm since 2016 to develop business in MENA and African regions.

menapharm.eu
4TECNIMEDE GROUP (Portugal)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Customer testimonial partner. Bruno Alves, Business Development Manager, describes Menapharm as a key partner for pharma companies entering MENA markets with long-term regional experience.

menapharm.eu
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

IQVIA is the world's largest life sciences data, technology, and consulting services provider. While far larger than Menapharm, its pharma market-entry and commercialization advisory practice competes for the same enterprise pharma clients.

TypeDirect peer
Description

ELC Group provides pharmaceutical regulatory affairs and compliance consulting services globally. It operates in the same professional-services regulatory niche as Menapharm, serving pharma clients seeking market authorization support.

TypeDirect peer
Description

ProPharma Group provides regulatory compliance, consulting, and quality assurance services to pharmaceutical and biotech companies. It mirrors Menapharm's professional-services model of helping pharma clients navigate complex regulatory environments.

TypeDirect peer
Description

PharmaLex is a specialized pharmaceutical regulatory affairs, compliance, and consulting services provider. It is directly comparable to Menapharm's regulatory support service line and shares the model of providing outsourced pharma expertise to companies entering new markets.

TypeDirect peer
Description

Arriello provides regulatory affairs, pharmacovigilance, and market-entry consulting to pharma companies expanding internationally, including in emerging markets. Its service model and target customer base align closely with Menapharm's offering.

TypeBroad incumbent
Description

Certara is a larger, established life sciences consulting and regulatory science platform serving global pharma and biotech clients. It operates in the same regulatory and market-entry advisory space as Menapharm but at significantly greater scale and with proprietary technology.

TypeBroad incumbent
Description

Parexel is one of the largest global CROs with deep regulatory, clinical, and market-access consulting capabilities for pharma. It is a broader incumbent that overlaps with Menapharm's regulatory and market-entry service lines but at much greater scale.

TypeDirect peer
Description

PharmaVentures is a specialist pharma business development and licensing advisory firm. It is comparable to Menapharm in serving pharma clients with strategic market-entry, out-licensing, and partnership support — though without MENA regional specialization.

TypeRegional player
Description

Acino is a pharmaceutical company headquartered in Switzerland with a strong commercial presence across the Middle East and Africa. It is comparable to Menapharm's customer base rather than its service model — sharing the MENA-focused pharma distribution footprint that Menapharm supports.

TypeOthers
Description

Informa Pharma Intelligence provides market intelligence, events, and consulting-adjacent services to the pharma industry, including the CPhI events Menapharm attends. It is an adjacent ecosystem player that influences the same client network rather than a direct competitor.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Menapharm Consulting

Pharmaceutical Market Consultingmenapharm.eu

Menapharm Consulting is a Malta-based pharmaceutical consulting firm that helps drug companies enter and operate in Middle East and African markets through four integrated services: business analysis, regulatory support, distributor management, and marketing and promotion.

What Menapharm Consulting does

Menapharm Consulting is a pharmaceutical market-entry and operations consulting firm that helps drug companies establish and run commercial presence across the Middle East and Africa. The company delivers four integrated services: Business Analysis (compliance checks, market research, SWOT, regulatory strategy, 5-year business plans), Regulatory Support (registration requirements, dossier compilation, submissions, variations, renewals), Distributor Management (selection, contract negotiation, inventory, sales reporting), and Marketing & Promotion (brand management, training materials, medical rep recruitment and management, forecasting and budgeting). Together these services function as a de facto regional office for clients that want MEA exposure without bearing the overhead of setting one up themselves.

The business model is professional-services based: engagements are quote-based with a shared-risk pricing structure, targeted exclusively at enterprise pharmaceutical clients. Go-to-market is relationship-driven and event-led, anchored on appearances at CPhI Worldwide (Milan, October 2026), WHX Dubai (January 2027) and Arab Health, supplemented by direct outreach via the company website. Disclosed clients include Leader Pharma (US), MAR-FARMA SRL (Italy, engaged since 2016) and TECNIMEDE GROUP (Portugal). The firm operates with nine employees from a Maltese headquarters (Lija) and a regional office in Abu Dhabi, with additional presence in the United Kingdom.

Following a recent merger with CPC Limited, Menapharm is now legally registered as CPC Limited in Malta while continuing to operate under the Menapharm brand. The company maintains a network of strategic partners and vetted distributors across MEA markets, which collectively represent a potential market access of approximately 850 million people. The MEA pharmaceuticals market is projected to grow from USD 30.1 billion in 2024 to USD 42.4 billion by 2030 at a 6.1% CAGR, providing the underlying tailwind for Menapharm's niche offering.

Menapharm Consulting firmographics

Firmographics
Name
Menapharm Consulting
Legal name
CPC Limited
Website
https://menapharm.eu
Company type
Private
Operating status
Operating
Headcount range
1–10 employees
Short description
Menapharm Consulting is a Malta-based pharmaceutical consulting firm that helps drug companies enter and operate in Middle East and African markets through four integrated services: business analysis, regulatory support, distributor management, and marketing and promotion.
Ownership category
akta.pro rank

Menapharm Consulting industry classification

Industry
Product category
Pharmaceutical Market Consulting
NAICS
Management Consulting Services (54161), Other Management Consulting Services (541618)
SIC
Services-Management Consulting Services (8742)
akta.pro industry
PRIMARYBPAHAIAM
Instrumentation, Controls & Automation Engineering Consulting

Keywords

  • Pharmaceutical consulting services
  • Market entry consulting
  • Regulatory affairs consulting
  • Pharmaceutical distributor management
  • Middle East Africa consulting

Where Menapharm Consulting is headquartered

Location

Headquarters

HQ city
Lija
HQ country
Malta
HQ region
Europe

Offices2 records

Markets served

Menapharm Consulting business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Consulting Services: Menapharm generates revenue through a range of consulting and advisory services including business analysis, regulatory support, distributor management, and marketing & promotion services. These are professional services billed to pharmaceutical companies seeking market entry in the Middle East and Africa.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Menapharm Consulting product offering

Product offering

Core offering

Menapharm Consulting provides pharmaceutical manufacturers with market entry and operational support services in the Middle East and African (MEA) markets. The firm offers business analysis, regulatory support, distributor management, and marketing & promotion services designed to help pharmaceutical companies establish or expand their presence in the MEA region without the overhead of setting up their own local offices.

Product overview

Menapharm Consulting offers a unified portfolio of four integrated consulting services for pharmaceutical companies seeking to enter Middle East and African markets. The core offering comprises Business Analysis (compliance checks, market research, and strategic planning), Regulatory Support (registration, dossier compilation, and compliance), Distributor Management (selection, negotiation, and ongoing management), and Marketing & Promotion (brand management, medical rep training, and sales support). These services function as a coordinated suite, providing the full scope of support equivalent to a regional office without the overhead costs, with a shared-risk business model designed to reduce market entry risk while enabling fast and efficient market penetration.

Differentiator

Problem solved

Functional benefit

Products and services

  • Business Analysis Market and business analysis service for pharmaceutical companies assessing entry or expansion into the Middle East and African markets. Delivered to pharmaceutical manufacturers seeking data-driven entry strategies.
  • Regulatory Support Regulatory affairs consulting service that helps pharmaceutical manufacturers navigate product registration, licensing, and compliance requirements across MEA jurisdictions.
  • Distributor Management Service that identifies, vets, and manages pharmaceutical distributors across Middle East and African markets on behalf of pharmaceutical manufacturers seeking local commercial partners.
  • Marketing & Promotion Marketing and product promotion services supporting pharmaceutical launches and ongoing brand activities across the Middle East and African markets.

Quantifiable outcome

  • Speed to market as the key competitive advantage

Companies that use Menapharm Consulting

Customer profile

Named customers3 records

Segments1 record

Ideal customer profiles1 record

Menapharm Consulting technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Menapharm Consulting partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and minor.

  • CPC LimitedcoreStrategic or Co-development PartnerMenapharm has merged with CPC Limited and will be registered as CPC Limited in Malta. They continue to operate under the Menapharm brand, which is widely recognized as a leading service provider to the pharma industry in the Middle East markets. This merger strengthens their operational infrastructure while maintaining their brand identity.
  • Leader Pharma (US)minorStrategic or Co-development PartnerCustomer testimonial partner. Dev Kumar, CCO, provided testimonial praising Menapharm's expertise in helping establish pharmaceutical presence in MENA markets.
  • MAR-FARMA SRL (Italy)minorStrategic or Co-development PartnerCustomer testimonial partner. Roberto Ricatti, CEO, has been working with Menapharm since 2016 to develop business in MENA and African regions.
  • TECNIMEDE GROUP (Portugal)minorStrategic or Co-development PartnerCustomer testimonial partner. Bruno Alves, Business Development Manager, describes Menapharm as a key partner for pharma companies entering MENA markets with long-term regional experience.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Menapharm Consulting competitors and assessment

Company assessment

Broad incumbents

  • IQVIA: IQVIA is the world's largest life sciences data, technology, and consulting services provider. While far larger than Menapharm, its pharma market-entry and commercialization advisory practice competes for the same enterprise pharma clients.
  • Certara: Certara is a larger, established life sciences consulting and regulatory science platform serving global pharma and biotech clients. It operates in the same regulatory and market-entry advisory space as Menapharm but at significantly greater scale and with proprietary technology.
  • Parexel International: Parexel is one of the largest global CROs with deep regulatory, clinical, and market-access consulting capabilities for pharma. It is a broader incumbent that overlaps with Menapharm's regulatory and market-entry service lines but at much greater scale.

Direct peers

  • ELC Group: ELC Group provides pharmaceutical regulatory affairs and compliance consulting services globally. It operates in the same professional-services regulatory niche as Menapharm, serving pharma clients seeking market authorization support.
  • ProPharma Group: ProPharma Group provides regulatory compliance, consulting, and quality assurance services to pharmaceutical and biotech companies. It mirrors Menapharm's professional-services model of helping pharma clients navigate complex regulatory environments.
  • PharmaLex: PharmaLex is a specialized pharmaceutical regulatory affairs, compliance, and consulting services provider. It is directly comparable to Menapharm's regulatory support service line and shares the model of providing outsourced pharma expertise to companies entering new markets.
  • Arriello: Arriello provides regulatory affairs, pharmacovigilance, and market-entry consulting to pharma companies expanding internationally, including in emerging markets. Its service model and target customer base align closely with Menapharm's offering.
  • PharmaVentures: PharmaVentures is a specialist pharma business development and licensing advisory firm. It is comparable to Menapharm in serving pharma clients with strategic market-entry, out-licensing, and partnership support — though without MENA regional specialization.

Regional players

  • Acino International: Acino is a pharmaceutical company headquartered in Switzerland with a strong commercial presence across the Middle East and Africa. It is comparable to Menapharm's customer base rather than its service model — sharing the MENA-focused pharma distribution footprint that Menapharm supports.

Others

  • Informa Pharma Intelligence: Informa Pharma Intelligence provides market intelligence, events, and consulting-adjacent services to the pharma industry, including the CPhI events Menapharm attends. It is an adjacent ecosystem player that influences the same client network rather than a direct competitor.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Menapharm Consulting social profiles

Digital presence

Menapharm Consulting financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Menapharm Consulting leadership team

Management profile

Number of profiles

Menapharm Consulting funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Menapharm Consulting M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Menapharm Consulting

What does Menapharm Consulting do?

Menapharm Consulting provides pharmaceutical manufacturers with market entry and operational support services in the Middle East and African (MEA) markets. The firm offers business analysis, regulatory support, distributor management, and marketing & promotion services designed to help pharmaceutical companies establish or expand their presence in the MEA region without the overhead of setting up their own local offices.

Is Menapharm Consulting a public or private company?

Menapharm Consulting is a private company. It is classified as unknown and is currently operating.

When was Menapharm Consulting founded?

Menapharm Consulting was founded in -1. It employs 1 to 10 people.

Where is Menapharm Consulting based?

Menapharm Consulting is headquartered in Lija, Malta, in the Europe region.

How does Menapharm Consulting make money?

One revenue line is on record: consulting Services.

Who are Menapharm Consulting's main competitors?

Broad incumbents on record are IQVIA, Certara and Parexel International. Direct peers are ELC Group, ProPharma Group, PharmaLex, Arriello and PharmaVentures. Acino International is listed as a regional player. Informa Pharma Intelligence is listed as an others.

Does Menapharm Consulting have an API?

No public API is recorded for Menapharm Consulting.

What industry is Menapharm Consulting in?

Menapharm Consulting's product category is Pharmaceutical Market Consulting. Its primary akta.pro industry code is BPAHAIAM, Instrumentation, Controls & Automation Engineering Consulting. Its NAICS code is 54161 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales